"Use of the 6-Min Walk Distance to Identify Variations in Treatment Benefits From Implantable Cardioverter-Defibrillator and Amiodarone"
JACC http://jacc.org/
Volume 63, Issue 23, June 2014
"Conclusions A baseline 6MW distance <288 m identified a subgroup of SCD-HeFT patients who were harmed by amiodarone therapy and did not benefit from ICD.
(Sudden Cardiac Death in Heart Failure Trial [SCD-HeFT]; NCT00000609)"
No comments:
Post a Comment